Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists

Monika Hifinger*, Mickael Hiligsmann, Sofia Ramiro, Johan L. Severens, Bruno Fautrel, Verity Watson, Annelies Boonen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)68-76
Number of pages9
JournalRheumatology
Volume56
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • clinicians
  • costs
  • cost-effectiveness
  • discrete choice experiment
  • patient preference
  • rheumatoid arthritis
  • MODIFYING ANTIRHEUMATIC DRUGS
  • RHEUMATOID-ARTHRITIS
  • EULAR RECOMMENDATIONS
  • COST-EFFECTIVENESS
  • HEALTH-CARE
  • ETANERCEPT
  • INFLIXIMAB
  • ADALIMUMAB
  • MANAGEMENT
  • THERAPY

Cite this